Athens Medical Group: Strategic collaboration with AEGEAN and Biomedical Group to conduct COVID-19 detection tests on passengers
Athens, December 17, 2020 – The Athens Medical Group is proceeding with a strategic partnership with AEGEAN and the Bioiatriki Group, offering the possibility of COVID-19 diagnostic testing to passengers of the largest Greek airline.
Having as a priority the containment of the pandemic in our country but also the further safety of travel, through this strategic partnership, the opportunity is given to everyone AEGEAN passengers who have a ticket, even for a trip months from now, to visit the websites www.aegeanair.com & www.olympicair.com and schedule the diagnostic test, the location, the day, and the time they wish, through a simple process.
By choosing the Athens Medical Group to perform the diagnostic test, passengers can visit one of the hospitals in its network, in Athens and Thessaloniki, or go to the specially designed areas “Covid – 19 TestingPoints“, at Athens International Airport “Eleftherios Venizelos” and Thessaloniki Airport “Macedonia”, respectively, in order to perform the test.
It is emphasized that with a view to preserving the health of patients and their companions, as well as the safety of nursing and medical personnel, in all clinics of the Athens Medical Group continue to fully implement and regularly update the strict measures and protocols for admission and stay that have been established, which will continue to be applied for as long as necessary.
On the occasion of the cooperation of the three Greek companies, the CEO of the Athens Medical Group, Dr. Vasilis Apostolopoulos, stated: “In a period when our country, but also the entire planet, is being tested universally, it is the responsibility of all of us to contribute, essentially, in this direction. The current partnership of the ATHENS MEDICAL GROUPwithAEGEAN and the BIOIATRIKI Group of Health Companies, is a shining example of the synergy of Greek companies, which join forces for the common good and the country’s rapid exit, our from the pandemic”.
“At AEGEAN we want to be close to our passengers, offering new possibilities and offers through new partnerships, especially today when their travels are limited due to the pandemic.
Thus, in collaboration with VIOIATRIKI GROUP and ATHENS MEDICAL GROUP we ensured for anyone who has a ticket with us, even for a trip months from now, the option to book through our website, using only their miles, or with special prices, diagnostic tests at a large number of points in our country.
Appointments for diagnostic tests can be scheduled, either because they are requested by the destination countries (usually 72 hours in advance), or independently of the trip, simply because they wish to do so for personal reasons and want to take advantage of the offers”, said AEGEAN’s CEO, Mr. Dimitris Gerogiannis.
The Chairman of the Board and CEO of BIOIATRIKI Group, Mr. Georgios Spanos, stated in this regard: “BIOATRIKI, having conducted over 100,000 tests since the beginning of the pandemic, is currently one of the largest Covid-19 Control Centers in the country.
From the very beginning, the Group has been supporting the effort to contain the pandemic, offering safe and high-quality services. We are proud of this partnership, which brings three major Greek companies together, with the aim of ensuring the safety of citizens’ movements and protecting their health.”
For more press information:
Savvas Karagiannis, CommunicationsManager, General Directorate of Business Development of Iatriki Group Athens
Tel.: 210 6287236, E-mail: s.karagiannis@iatriko.gr
